EJNMMI research (EJNMMI Res)

Journal PubWeight™ 385.95‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Test-retest analysis of a non-invasive method of quantifying [(11)C]-PBR28 binding in Alzheimer's disease. 2016 1.46
2 Carotid atherosclerotic plaques standardised uptake values: software challenges and reproducibility. 2017 1.39
3 The ultimate radiochemical nightmare: upon radio-iodination of Botulinum neurotoxin A, the introduced iodine atom itself seems to be fatal for the bioactivity of this macromolecule. 2015 1.39
4 Toxicity and radiation dosimetry studies of the serotonin transporter radioligand [(18) F]AFM in rats and monkeys. 2014 1.38
5 Absorption, distribution and excretion of intravenously injected (68)Ge/ (68)Ga generator eluate in healthy rats, and estimation of human radiation dosimetry. 2015 1.38
6 Quantitative (18)F-fluorocholine positron emission tomography for prostate cancer: correlation between kinetic parameters and Gleason scoring. 2017 1.37
7 Quantitative assessment of brown adipose tissue metabolic activity and volume using 18F-FDG PET/CT and β3-adrenergic receptor activation. 2011 1.31
8 Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects. 2011 1.29
9 Anaesthesia and physiological monitoring during in vivo imaging of laboratory rodents: considerations on experimental outcomes and animal welfare. 2012 1.25
10 Early side effects and first results of radioligand therapy with (177)Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study. 2015 1.23
11 A computational pipeline for quantification of pulmonary infections in small animal models using serial PET-CT imaging. 2013 1.17
12 Inert coupling of IRDye800CW to monoclonal antibodies for clinical optical imaging of tumor targets. 2011 1.16
13 Assessment of tumour size in PET/CT lung cancer studies: PET- and CT-based methods compared to pathology. 2012 1.15
14 A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancer. 2012 1.15
15 Post-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheres. 2013 1.14
16 68Ga-DOTATATE PET/CT for the detection of inflammation of large arteries: correlation with18F-FDG, calcium burden and risk factors. 2012 1.14
17 Optimized dose regimen for whole-body FDG-PET imaging. 2013 1.12
18 Synthesis and preclinical evaluation of DOTAGA-conjugated PSMA ligands for functional imaging and endoradiotherapy of prostate cancer. 2014 1.08
19 FDG-PET is a good biomarker of both early response and acquired resistance in BRAFV600 mutant melanomas treated with vemurafenib and the MEK inhibitor GDC-0973. 2012 1.08
20 Progression of bone metastases in patients with prostate cancer - automated detection of new lesions and calculation of bone scan index. 2013 1.06
21 Comparative gallium-68 labeling of TRAP-, NOTA-, and DOTA-peptides: practical consequences for the future of gallium-68-PET. 2012 1.05
22 Nuclear imaging of inflammation: homing-associated molecules as targets. 2013 1.04
23 18F-fluoride PET: changes in uptake as a method to assess response in bone metastases from castrate-resistant prostate cancer patients treated with 223Ra-chloride (Alpharadin). 2011 1.03
24 SUVref: reducing reconstruction-dependent variation in PET SUV. 2011 1.02
25 Measurement of metabolic tumor volume: static versus dynamic FDG scans. 2011 1.02
26 (64)Cu-DOTA-trastuzumab PET imaging and HER2 specificity of brain metastases in HER2-positive breast cancer patients. 2015 1.01
27 Hemoglobin level significantly impacts the tumor cell survival fraction in humans after internal radiotherapy. 2012 1.01
28 Evaluation of F-nifene binding to α4β2 nicotinic receptors in the rat brain using microPET imaging. 2011 1.00
29 Failure of annexin-based apoptosis imaging in the assessment of antiangiogenic therapy effects. 2011 0.99
30 Effects of internal low-dose irradiation from 131I on gene expression in normal tissues in Balb/c mice. 2011 0.99
31 Correction of scan time dependence of standard uptake values in oncological PET. 2014 0.99
32 Comparison of PET template-based and MRI-based image processing in the quantitative analysis of C11-raclopride PET. 2014 0.98
33 Transcriptional response of BALB/c mouse thyroids following in vivo astatine-211 exposure reveals distinct gene expression profiles. 2012 0.98
34 Cerebral blood flow and glucose metabolism in healthy volunteers measured using a high-resolution PET scanner. 2012 0.97
35 Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT. 2013 0.97
36 Emerging role of radiolabeled nanoparticles as an effective diagnostic technique. 2012 0.96
37 A novel method to quantify IRDye800CW fluorescent antibody probes ex vivo in tissue distribution studies. 2012 0.96
38 Radiofluorination using aluminum-fluoride (Al18F). 2013 0.96
39 A comparative 18F-FDG PET/CT imaging of experimental Staphylococcus aureus osteomyelitis and Staphylococcus epidermidis foreign-body-associated infection in the rabbit tibia. 2012 0.95
40 High resolution tumor targeting in living mice by means of multispectral optoacoustic tomography. 2012 0.95
41 Suitability of bilateral filtering for edge-preserving noise reduction in PET. 2011 0.95
42 Post-radioembolization yttrium-90 PET/CT - part 1: diagnostic reporting. 2013 0.95
43 Quantification of 99mTc-DPD concentration in the lumbar spine with SPECT/CT. 2013 0.95
44 The PET-derived tumor-to-blood standard uptake ratio (SUR) is superior to tumor SUV as a surrogate parameter of the metabolic rate of FDG. 2013 0.94
45 Comparison of cyclic RGD peptides for αvβ3 integrin detection in a rat model of myocardial infarction. 2013 0.94
46 Targeting CEA in Pancreas Cancer Xenografts with a Mutated scFv-Fc Antibody Fragment. 2011 0.94
47 Uptake of 68gallium in atherosclerotic plaques in LDLR-/-ApoB100/100 mice. 2011 0.94
48 Imaging technologies for preclinical models of bone and joint disorders. 2011 0.94
49 Pilot study: use of gallium-68 PSMA PET for detection of metastatic lesions in patients with renal tumour. 2016 0.94
50 Radiolabeling polymeric micelles for in vivo evaluation: a novel, fast, and facile method. 2016 0.93
Next 50